fashion -WSS

fashion

author：Wikipedia 2025-09-30 14:59:02 - browse：955

Marc Tessier Lavigne (center) retracted two Science papers on the day his resignation as Stanford president takes effect. Mattarella in San Francisco

After an expansive investigation found manipulated data and other issues with papers co-authored by Stanford’s now ex-president Marc Tessier-Lavigne, the prominent neuroscientist on Thursday retracted two studies published in the journal Science in 2001 — over the objection of a former postdoctoral researcher who played a leading role in both projects.

The retractions come the same day that Tessier-Lavigne’s resignation as Stanford president takes effect. His departure was prompted by a 95-page report released by a special committee of the university’s Board of Trustees, which recruited outside scientists and a former federal judge to investigate a dozen papers Tessier-Lavigne co-authored between 1999 and 2009, years before becoming the university’s leader.

The panel concluded that he did not personally engage in scientific misconduct, but it uncovered manipulated data in some studies Tessier-Lavigne had supervised and found that he took insufficient steps to “decisively and forthrightly” correct these studies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： A deep dive into Applied Therapeutics’ data, and questions on Cassava

WSS

Listen: PBM conflicts, RSV vaccines, & the future of flu season

Bacterial infection may be ‘key event’ in endometriosis, study says

Pfizer's Covid pill remains 89% effective in final analysis, company says

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Listen: Biogen's messy board & Laronde's data problem

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

focus

fashion

Wikipedia

Jerome Adams on the need for new antivirals for Covid

The drug industry has found itself all alone in Washington

Activists slam private health insurers over coverage restrictions

Sen. Paul opposes bill to ban Chinese biotechs

23andMe had bad news about my health. I wish a person had delivered it

RaDonda Vaught case: a double standard for nurses, physicians

Jerome Adams on the need for new antivirals for Covid

First medicine developed to treat MASH expected to be approved soon

Apple is now the first public company to be valued at $3 trillion

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

explore

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Meta looks to target Twitter with a rival app called Threads

Meta looks to target Twitter with a rival app called Threads

How to bring more disabled researchers into academia

Grail is spending more than ever lobbying Congress

entertainment

explore

focus

knowledge